A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment

Volumn 38, Issue SUPPL. 1, 2010, Pages

  Roman, Paul M ^a   Abraham, Amanda J ^a   Rothrauff, Tanja C ^a   Knudsen, Hannah K ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Clinical Trials Network; Dissemination research; Evidence based practice; Innovation adoption; Interorganizational relationships

Indexed keywords

BUPRENORPHINE;

ARTICLE; CLINICAL RESEARCH; COMMUNITY CARE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEALTH CARE PERSONNEL; HUMAN; INFORMATION DISSEMINATION; INTERDISCIPLINARY COMMUNICATION; LONGITUDINAL STUDY; MOTIVATION; ORGANIZATION; PRIORITY JOURNAL; TRUST;

BUPRENORPHINE; CLINICAL TRIALS AS TOPIC; COMMUNITY HEALTH SERVICES; DIFFUSION OF INNOVATION; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; MOTIVATION; NARCOTIC ANTAGONISTS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNITED STATES;

EID: 77950292999     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2009.12.008     Document Type: Article

References (27)

1. Abraham, A. J., Knudsen, H. K., Rothrauff, T. C., & Roman, P. M. (in press). The adoption and implementation of alcohol pharmacotherapies in the Clinical Trials Network. Journal of Substance Abuse Treatment.
2. Agrawal M., Grady C., Fairclaough D.L., Meropol N.J., Maynard K., Emanuel E.J. Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology 2006, 24:4479-4484.
3. Barnato A.E., Llewellyn-Thomas H.A., Peters E.M., Siminoff L., Collins E.D., Barry M.J. Communication and decision making in cancer care: Setting research priorities for decision support/patients' decision aids. Medical Decision Making 2007, 27:626-634.
4. Brown B. Reducing impediments to technology transfer in drug abuse. Reviewing the behavioral science knowledge base on technology transfer 1995, 169-185. National Institute on Drug Abuse, Rockville, MD, (NIDA Research Monograph 155, NIH Publication No. 95-4035). T.E. Backer, S.L. David, G. Soucy (Eds.).
5. Ducharme, L.J., Knudsen, H.K., Abraham, A.J., & Roman, P.M., (in press). Counselor attitudes toward the use of contingency management in addiction treatment. The American Journal on Addictions.
6. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
7. Ducharme L.J., Roman P.M. Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. Journal of Substance Abuse Treatment 2009, 37:90-94.
8. Fiellin D.A. The first three years of buprenorphine in the United States: Experience to date and future directions. Journal of Addiction Medicine 2007, 1:62-67.
9. Gaston C.M., Mitchell G. Information giving and decision-making in patients with advanced cancer: A systematic review. Social Science & Medicine 2005, 61:2252-2264.
10. Guydish J., Tajima B., Manser S.T., Jessup M. Strategies to encourage adoption in multi-site clinical trials. Journal of Substance Abuse Treatment 2007, 32:177-188.
11. Hanson G.R., Leshner A.I., Tai B. Putting drug abuse research to use in real-life settings. Journal of Substance Abuse Treatment 2002, 23:69-70.
12. Hubbard G., Kidd L., Donaghy E., McDonald C., Kearney N. A review of literature about involving people affected by cancer in research, policy and planning and practice. Patient Education and Counseling 2007, 65:21-33.
13. Knudsen H.K., Abraham A.J., Johnson J.A., Roman P.M. Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2009, 37:307-312.
14. Knudsen H.K., Ducharme L.J., Roman P.M. Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine. The American Journal on Addictions 2007, 16:365-371.
15. Knudsen H.K., Ducharme L.J., Roman P.M. Research participation and turnover intention: An exploratory analysis of substance abuse counselors. Journal of Substance Abuse Treatment 2007, 33:211-217.
16. Knudsen H.K., Ducharme L.J., Roman P.M. Clinical supervision, emotional exhaustion, and turnover intention: A study of substance abuse treatment counselors in NIDA's Clinical Trials Network. Journal of Substance Abuse Treatment 2008, 35:387-395.
17. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, 27-55. National Academy Press, Washington. S. Lamb, M.R. Greenlick, D. McCarty (Eds.).
18. Marsh J., Cao D., Guerrero E., Shin H.C. Need-Service matching in substance abuse treatment: Racial/Ethnic differences. Evaluation and Program Planning 2009, 32:43-51.
19. McCarty D., Fuller B., Kaskutas L.A., Wendt W.W., Nunes E.V., Miller M., et al. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence 2008, 92:200-207.
20. McLellan A.T., Hagan T.A., Levine M., et al. Supplemental social services improve outcomes in public addiction treatment. Addiction 1998, 93:1489-1499.
21. McLellan A.T., McKay J.R. The treatment of addiction: What can research offer practice?. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, 147-185. National Academy Press, Washington. S. Lamb, M.R. Greenlick, D. McCarty (Eds.).
22. Mee-Lee D., Gartner L., Miller M., Schulman G.R., Wilford B.B. Patient placement criteria for the treatment of substance-related disorders 1996, American Society of Addiction Medicine, Chevy Chase, MD. 2nd ed.
23. Naranjo C.A., Bremmer K.E. Dissemination of research results regarding the pharmacotherapy of substance abuse: Case examples and a critical review. Substance Abuse 1996, 17:39-50.
24. National Cancer Institute J Decades of progress: 1983-2003. Community Clinical Oncology Program 2004, National Institutes of Health Publication No. 01-5562, Bethesda, MD.
25. Perron B.E., Bright C.L. The influence of legal coercion on dropout from substance abuse treatment: Results from a national survey. Drug and Alcohol Dependence 2007, 92:123-131.
26. Rogers E.M. Diffusion of innovations 2003, Free Press, New York. 5th ed.
27. Zickler P. Clinical Trials Network will speed testing and delivery of new drug abuse therapies. NIDA Notes 1999, 14. Accessed on November 24, 2009 at:. http://www.drugabuse.gov/Nida_Notes/NNVol14N1/CTN.html.